Explore ARK’s Newsletter
A weekly newsletter curated by our teams of analysts and designed to keep you engaged with disruptive innovation.
#434
Oct 06, 2024
#434: Can The FDA Modernization Act 2.0 Revolutionize Drug Discovery?, & More...
In this issue:
- 1. Can The FDA Modernization Act 2.0 Revolutionize Drug Discovery?
- 2. Will Fission Or Fusion Shape AI’s Nuclear Future?
- 3. Cerebras’s Massive Wafer-Scale CS-3 Chip Is Outcomputing The Competition
- 4. OpenAI Revealed Important New Capabilities During “Dev Day 2024”
- 5. A Breakthrough In Stem-Cell Therapy Offers Hope For Diabetes
#432
Sep 23, 2024
#432: Klarna’s Open-AI Powered Shopping Assistant Could Redefine The Consumer Experience, & More
In this issue:
#431
Sep 16, 2024
Read
#430
Sep 09, 2024
#430: DeepMind’s New AI System, AlphaProteo, Should Accelerate The Discovery Of New Drugs, & More
In this issue:
- 1. DeepMind’s New AI System, AlphaProteo, Should Accelerate The Discovery Of New Drugs
- 2. Tesla Unveiled Its Roadmap For Full Self Driving
- 3. The Base Layer 2 Network Just Hosted The First AI-To-AI Crypto Payment
- 4. Replit Agent Is Taking More Steps Toward Democratizing Access To Software Development
#429
Sep 02, 2024
#429: Single-Cell And Spatial Genomics Are Revolutionizing Cancer Prognostics And Treatment, & More
In this issue:
- 1. Single-Cell And Spatial Genomics Are Revolutionizing Cancer Prognostics And Treatment
- 2. AI-Integrated Smart Wallets Could Create A New Wave Of E-Commerce
- 3. The Arrest Of Telegram’s CEO Is Likely To Have Regulatory Implications For Innovation In Europe
- 4. Generative AI Is Finding An Important Use Case In Small Molecule Drug Discovery
Subscribe to ARK’s Innovation Research